Ligand Pharm (LGND)

$159.76 +0.97 (0.61%)
Market Cap 3.12B
Revenue (ttm) 167.13M
Net Income (ttm) -4.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 642.75
Profit Margin -2.41%
Debt to Equity Ratio 0.00
Volume 102,100
Avg Vol 229,986
Day's Range N/A - N/A
Shares Out 19.60M
Stochastic %K 83%
Beta 0.85
Analysts Strong Sell
Price Target $156.62

Company Profile

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI, a dual endothelin and angiotensin II receptor antagonist for immunoglobulin A nephropathy; Ohtuvayre for respiratory disease; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pn...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 550 7500
Address:
555 Heritage Drive, Suite 200, Jupiter, United States
Estimize
Estimize Aug. 20 at 1:00 PM
Wall St is expecting 1.90 EPS for $LGND Q3 [Reporting 11/05 BMO] http://www.estimize.com/intro/lgnd?chart=historical&metric_name=eps&utm_co
0 · Reply
NavalnyTheGreat
NavalnyTheGreat Aug. 18 at 6:11 PM
$LGND Why is this blowing up rn? Just checked my stake, see it's up 50% since May. What happened?
2 · Reply
Doozio
Doozio Aug. 14 at 7:35 PM
$RIGL that’s because $XBI wasn’t in $RYTM n $HRMY then. Bahhhts its gonna be $LGND ary now 🐒🍌🧠⏰♾️. 🍿
1 · Reply
tyogs
tyogs Aug. 14 at 12:02 AM
$LGND 180
0 · Reply
Doozio
Doozio Aug. 12 at 2:35 PM
moar volume on a $LGND ary turnaround Tuesday as $XBI $IWM become obviously obvious 🐒🍌🧠⏰♾️
0 · Reply
Doozio
Doozio Aug. 11 at 7:43 PM
$LGND ary volume support wen all the 🐑 been SPOT. 🐒🍌🧠⏰♾️
0 · Reply
garygb
garygb Aug. 11 at 7:02 PM
$LGND I'm holding
0 · Reply
ZacksSCR
ZacksSCR Aug. 11 at 3:58 PM
$LGND: Getting In Tune with MedTech https://buff.ly/ZZ1Vlco
0 · Reply
Doozio
Doozio Aug. 11 at 3:51 PM
$LENZ it ain’t a MNDY 🐑 suck in wen it’s a $LGND ary 🐑 shake into the huckleberries 🐒🍌🧠⏰♾️
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 6:19 PM
RBC Capital updates rating for Ligand Pharmaceuticals ( $LGND ) to Outperform, target set at 155 → 185.
0 · Reply
Latest News on LGND
Ligand to Participate in September Investor Conferences

Aug 19, 2025, 4:00 PM EDT - 7 days ago

Ligand to Participate in September Investor Conferences

Ligand Announces Closing of Convertible Senior Notes Offering

Aug 14, 2025, 4:00 PM EDT - 12 days ago

Ligand Announces Closing of Convertible Senior Notes Offering

Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering

Aug 11, 2025, 11:46 PM EDT - 15 days ago

Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering

Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030

Aug 11, 2025, 7:00 AM EDT - 16 days ago

Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030

Ligand Pharmaceuticals Incorporated (LGND) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 8:01 PM EDT - 19 days ago

Ligand Pharmaceuticals Incorporated (LGND) Q2 2025 Earnings Call Transcript

Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance

Aug 7, 2025, 7:00 AM EDT - 20 days ago

Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

Jul 31, 2025, 4:01 PM EDT - 26 days ago

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

MDT OBIO

Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 24, 2025, 7:00 AM EDT - 4 weeks ago

Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025

Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™

Jul 10, 2025, 8:00 AM EDT - 6 weeks ago

Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™

Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement

Jul 2, 2025, 7:00 AM EDT - 2 months ago

Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement

Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics

Jul 2, 2025, 7:00 AM EDT - 2 months ago

Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics

Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward

Jun 24, 2025, 2:47 PM EDT - 2 months ago

Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward

Ligand Announces 2025 Investor Day in New York City

Jun 11, 2025, 7:00 AM EDT - 2 months ago

Ligand Announces 2025 Investor Day in New York City

Ligand to Ring the Nasdaq Opening Bell on May 19, 2025

May 14, 2025, 7:00 AM EDT - 3 months ago

Ligand to Ring the Nasdaq Opening Bell on May 19, 2025

Ligand Pharmaceuticals Incorporated (LGND) Q1 2025 Earnings Call Transcript

May 8, 2025, 2:19 PM EDT - 3 months ago

Ligand Pharmaceuticals Incorporated (LGND) Q1 2025 Earnings Call Transcript

Ligand Reports First Quarter 2025 Financial Results

May 8, 2025, 7:00 AM EDT - 3 months ago

Ligand Reports First Quarter 2025 Financial Results

Ligand to Participate in May Investor Conferences

May 1, 2025, 7:00 AM EDT - 4 months ago

Ligand to Participate in May Investor Conferences

Ligand to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 7:00 AM EDT - 4 months ago

Ligand to Report First Quarter 2025 Financial Results on May 8, 2025

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

Apr 17, 2025, 6:00 AM EDT - 4 months ago

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

Ligand to Participate in March Investor Conferences

Mar 3, 2025, 7:00 AM EST - 6 months ago

Ligand to Participate in March Investor Conferences

Ligand Pharmaceuticals Incorporated (LGND) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 3:06 PM EST - 6 months ago

Ligand Pharmaceuticals Incorporated (LGND) Q4 2024 Earnings Call Transcript

Ligand Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 27, 2025, 7:00 AM EST - 6 months ago

Ligand Reports Fourth Quarter and Full Year 2024 Financial Results

Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences

Feb 25, 2025, 7:00 AM EST - 6 months ago

Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences

XOMA

Ligand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Feb 13, 2025, 7:00 AM EST - 6 months ago

Ligand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 6, 2025, 7:00 AM EST - 7 months ago

Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Looking Back On Ligand Pharmaceuticals

Feb 3, 2025, 2:59 PM EST - 7 months ago

Looking Back On Ligand Pharmaceuticals

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

Jan 13, 2025, 6:10 PM EST - 8 months ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD GSK

Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance

Dec 10, 2024, 9:00 AM EST - 9 months ago

Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance

Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies

Nov 24, 2024, 6:50 AM EST - 9 months ago

Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies

Ligand to Present at Stifel 2024 Healthcare Conference

Nov 14, 2024, 8:00 AM EST - 10 months ago

Ligand to Present at Stifel 2024 Healthcare Conference

Ligand Pharmaceuticals Incorporated (LGND) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 8:07 AM EST - 10 months ago

Ligand Pharmaceuticals Incorporated (LGND) Q3 2024 Earnings Call Transcript

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance

Nov 7, 2024, 7:00 AM EST - 10 months ago

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance

Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston

Nov 1, 2024, 8:01 AM EDT - 10 months ago

Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston

Ligand to Report Third Quarter 2024 Financial Results on November 7, 2024

Oct 23, 2024, 4:01 PM EDT - 10 months ago

Ligand to Report Third Quarter 2024 Financial Results on November 7, 2024

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

Sep 6, 2024, 9:20 AM EDT - 1 year ago

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

TVTX

CD40 Ligand Market - Global Monoclonal Antibody, Polyclonal Antibody, Autoimmune Disease Treatment, Immunotherapy, Vaccine Development Forecast 2024-2030

Aug 30, 2024, 4:04 AM EDT - 1 year ago

CD40 Ligand Market - Global Monoclonal Antibody, Polyclonal Antibody, Autoimmune Disease Treatment, Immunotherapy, Vaccine Development Forecast 2024-2030

Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference

Aug 20, 2024, 9:00 AM EDT - 1 year ago

Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference

Ligand Pharmaceuticals Incorporated (LGND) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 10:58 PM EDT - 1 year ago

Ligand Pharmaceuticals Incorporated (LGND) Q2 2024 Earnings Call Transcript

Ligand Reports Second Quarter 2024 Financial Results

Aug 6, 2024, 4:01 PM EDT - 1 year ago

Ligand Reports Second Quarter 2024 Financial Results

Ligand Pharmaceuticals: Solid Performer Performing Solidly

Jul 29, 2024, 2:43 PM EDT - 1 year ago

Ligand Pharmaceuticals: Solid Performer Performing Solidly

Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement

Jul 24, 2024, 6:30 AM EDT - 1 year ago

Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement

Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 23, 2024, 4:01 PM EDT - 1 year ago

Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024

Ligand to Acquire APEIRON Biologics AG for $100 Million

Jul 8, 2024, 7:00 AM EDT - 1 year ago

Ligand to Acquire APEIRON Biologics AG for $100 Million

Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years

Jun 27, 2024, 8:00 AM EDT - 1 year ago

Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years

Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults

Jun 18, 2024, 8:00 AM EDT - 1 year ago

Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults

Ligand to Participate in Upcoming Investor Conferences

May 23, 2024, 4:59 PM EDT - 1 year ago

Ligand to Participate in Upcoming Investor Conferences

Ligand Pharmaceuticals Incorporated (LGND) Q1 2024 Earnings Call Transcript

May 7, 2024, 11:03 PM EDT - 1 year ago

Ligand Pharmaceuticals Incorporated (LGND) Q1 2024 Earnings Call Transcript

Ligand Reports First Quarter 2024 Financial Results

May 7, 2024, 4:00 PM EDT - 1 year ago

Ligand Reports First Quarter 2024 Financial Results

Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement

May 7, 2024, 7:30 AM EDT - 1 year ago

Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement

AGEN

Ligand: Buy This Pharma Royalty Aggregator To Generate Growth In Your Portfolio

Apr 29, 2024, 10:01 PM EDT - 1 year ago

Ligand: Buy This Pharma Royalty Aggregator To Generate Growth In Your Portfolio

Estimize
Estimize Aug. 20 at 1:00 PM
Wall St is expecting 1.90 EPS for $LGND Q3 [Reporting 11/05 BMO] http://www.estimize.com/intro/lgnd?chart=historical&metric_name=eps&utm_co
0 · Reply
NavalnyTheGreat
NavalnyTheGreat Aug. 18 at 6:11 PM
$LGND Why is this blowing up rn? Just checked my stake, see it's up 50% since May. What happened?
2 · Reply
Doozio
Doozio Aug. 14 at 7:35 PM
$RIGL that’s because $XBI wasn’t in $RYTM n $HRMY then. Bahhhts its gonna be $LGND ary now 🐒🍌🧠⏰♾️. 🍿
1 · Reply
tyogs
tyogs Aug. 14 at 12:02 AM
$LGND 180
0 · Reply
Doozio
Doozio Aug. 12 at 2:35 PM
moar volume on a $LGND ary turnaround Tuesday as $XBI $IWM become obviously obvious 🐒🍌🧠⏰♾️
0 · Reply
Doozio
Doozio Aug. 11 at 7:43 PM
$LGND ary volume support wen all the 🐑 been SPOT. 🐒🍌🧠⏰♾️
0 · Reply
garygb
garygb Aug. 11 at 7:02 PM
$LGND I'm holding
0 · Reply
ZacksSCR
ZacksSCR Aug. 11 at 3:58 PM
$LGND: Getting In Tune with MedTech https://buff.ly/ZZ1Vlco
0 · Reply
Doozio
Doozio Aug. 11 at 3:51 PM
$LENZ it ain’t a MNDY 🐑 suck in wen it’s a $LGND ary 🐑 shake into the huckleberries 🐒🍌🧠⏰♾️
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 6:19 PM
RBC Capital updates rating for Ligand Pharmaceuticals ( $LGND ) to Outperform, target set at 155 → 185.
0 · Reply
IN0V8
IN0V8 Aug. 8 at 2:25 PM
$LGND RBC raises target price to $185 from $155
0 · Reply
Doozio
Doozio Aug. 7 at 7:49 PM
$INCY $WGS are biotechs that act like $LGND ary 🧠leader🐑 ready to continue TTWO $ASND during 🐒🍌🧠⏰♾️
0 · Reply
tyogs
tyogs Aug. 7 at 12:48 PM
$LGND 180-200 soon
0 · Reply
Rolfthewild
Rolfthewild Aug. 7 at 12:42 AM
$LGND Yessirr looks like a decent buy assuming it isn't pumbled at open tomorrow.
0 · Reply
Doozio
Doozio Aug. 6 at 9:12 PM
By FRYday? They did say all that 🐑 news about Tarrifs was SPOT and 🐒🍌🧠⏰♾️ wus gonna be $LGND ary.
0 · Reply
Doozio
Doozio Aug. 5 at 11:28 PM
$LGND s of the fall. 🐒🍌🧠⏰♾️
0 · Reply
FannyPackin
FannyPackin Aug. 5 at 11:26 PM
$LGND 160 this fall?
0 · Reply
Doozio
Doozio Aug. 5 at 8:50 PM
$XBI has gotten its RYTM and they supported it in $HRMY as da $HALO gaps n GOGO’s to protect YO as its about to get fookin $LGND ary NEXT as the 🧠 spreads 🐒🍌🧠⏰♾️
0 · Reply
CryptoSenderX
CryptoSenderX Jul. 25 at 8:28 AM
$PTHS 🪐 . Low Cap with $60 price target analysis . 600k Shares Free Float I OS Locked Up . Backed by $LGND ( 50% Stake in the Company ) . Commercialising the only FDA Approved Product The next $DRUG I $RGC I $STEC I is here 🎆 Always do your own DD 👌🏻
0 · Reply
CryptoSenderX
CryptoSenderX Jul. 24 at 12:56 PM
$LGND own a 56% stake in $PTHS
0 · Reply
Doozio
Doozio Jul. 24 at 10:30 AM
$XBI wen all da $DRUG zzzz go in $RYTM and $HRMY n this gets $LGND ary in 🐒🍌🧠⏰♾️
0 · Reply
Doozio
Doozio Jul. 19 at 1:20 AM
YO this 💩 has officially gotten $LGND ary during 🐒🍌🧠⏰♾️
0 · Reply